Walgreens Boots Alliance (NASDAQ:WBA) had its price objective lowered by Loop Capital to $77.00 in a research report report published on Wednesday, March 27th, The Fly reports. Loop Capital currently has a buy rating on the pharmacy operator’s stock. The analysts noted that the move was a valuation call.
WBA has been the topic of several other reports. Zacks Investment Research raised Walgreens Boots Alliance from a sell rating to a hold rating in a research report on Monday, March 4th. Bank of America reissued an underperform rating and issued a $62.00 price objective (down from $69.00) on shares of Walgreens Boots Alliance in a research report on Friday, March 8th. BidaskClub raised Walgreens Boots Alliance from a sell rating to a hold rating in a research report on Thursday, February 14th. UBS Group initiated coverage on Walgreens Boots Alliance in a research report on Thursday, January 17th. They issued a sell rating and a $70.00 price objective on the stock. Finally, Needham & Company LLC raised Walgreens Boots Alliance to a buy rating and set a $94.00 price objective on the stock in a research report on Thursday, December 20th. Five equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have issued a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus price target of $68.00.
Shares of WBA traded down $0.51 during trading hours on Wednesday, hitting $54.63. The stock had a trading volume of 7,991,280 shares, compared to its average volume of 9,288,540. The company has a current ratio of 0.78, a quick ratio of 0.38 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $49.95 billion, a P/E ratio of 9.07, a price-to-earnings-growth ratio of 1.11 and a beta of 0.86. Walgreens Boots Alliance has a 12-month low of $53.32 and a 12-month high of $86.31.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Monday, May 20th will be paid a $0.44 dividend. The ex-dividend date is Friday, May 17th. This represents a $1.76 dividend on an annualized basis and a yield of 3.22%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 29.24%.
In other news, COO Ornella Barra purchased 18,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was acquired at an average cost of $54.56 per share, for a total transaction of $982,080.00. Following the completion of the purchase, the chief operating officer now owns 26,425 shares of the company’s stock, valued at $1,441,748. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 15.73% of the stock is currently owned by company insiders.
A number of hedge funds have recently modified their holdings of the business. CSat Investment Advisory L.P. raised its holdings in shares of Walgreens Boots Alliance by 12.1% during the fourth quarter. CSat Investment Advisory L.P. now owns 1,920 shares of the pharmacy operator’s stock valued at $131,000 after buying an additional 208 shares during the last quarter. Pathlight Investors LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $524,000. James Investment Research Inc. bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $963,000. Tiemann Investment Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 2.7% during the fourth quarter. Tiemann Investment Advisors LLC now owns 22,190 shares of the pharmacy operator’s stock valued at $1,516,000 after buying an additional 586 shares during the last quarter. Finally, Newman Dignan & Sheerar Inc. raised its holdings in shares of Walgreens Boots Alliance by 22.9% during the first quarter. Newman Dignan & Sheerar Inc. now owns 4,616 shares of the pharmacy operator’s stock valued at $292,000 after buying an additional 861 shares during the last quarter. Institutional investors own 65.05% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: Key terms to understand channel trading
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.